Skip to main content
. 2025 Dec 7;26(24):11820. doi: 10.3390/ijms262411820
ADRs Adverse drug reactions
EMT Epithelial–mesenchymal transition
GDSC Genomics of Drug Sensitivity in Cancer
GSEA Gene set enrichment analysis
HGSOC High-grade serous ovarian cancer
HR Homologous recombination
HRD Homologous recombination deficiency
HRI Homologous recombination-intermediate
HRP Homologous recombination-proficient
PARP Poly (ADP-ribose) polymerase
PPI Protein–protein interaction
RECAP Recombination CAPacity
SRB Sulforhodamine-B